Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merus Raises $300m After ASCO Success

Jun 04 2025

• By Andrew McConaghie

Related Content

Merus Bispecific Impresses In Head And Neck Cancer

May 23 2025

Merck Set To Add Perioperative Head-And-Neck Cancer To Keytruda Label

Apr 28 2025

Related Companies

Merus N.V.

Bicara Therapeutics, Inc.

More from ASCO

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window